These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1631135)

  • 1. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity.
    Kato K; Cox AD; Hisaka MM; Graham SM; Buss JE; Der CJ
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6403-7. PubMed ID: 1631135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
    Cox AD; Hisaka MM; Buss JE; Der CJ
    Mol Cell Biol; 1992 Jun; 12(6):2606-15. PubMed ID: 1375323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity.
    Quilliam LA; Huff SY; Rabun KM; Wei W; Park W; Broek D; Der CJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8512-6. PubMed ID: 8078913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.
    Jackson JH; Cochrane CG; Bourne JR; Solski PA; Buss JE; Der CJ
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3042-6. PubMed ID: 2183224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polylysine domain of K-ras 4B protein is crucial for malignant transformation.
    Jackson JH; Li JW; Buss JE; Der CJ; Cochrane CG
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12730-4. PubMed ID: 7809111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21ras is modified by a farnesyl isoprenoid.
    Casey PJ; Solski PA; Der CJ; Buss JE
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8323-7. PubMed ID: 2682646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B).
    Hancock JF; Cadwallader K; Marshall CJ
    EMBO J; 1991 Mar; 10(3):641-6. PubMed ID: 2001678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1.
    Manolaridis I; Kulkarni K; Dodd RB; Ogasawara S; Zhang Z; Bineva G; Reilly NO; Hanrahan SJ; Thompson AJ; Cronin N; Iwata S; Barford D
    Nature; 2013 Dec; 504(7479):301-5. PubMed ID: 24291792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxyl-terminal CXXX sequence of Gi alpha, but not Rab5 or Rab11, supports Ras processing and transforming activity.
    Cox AD; Graham SM; Solski PA; Buss JE; Der CJ
    J Biol Chem; 1993 Jun; 268(16):11548-52. PubMed ID: 8505289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polybasic domain allows nonprenylated Ras proteins to function in Saccharomyces cerevisiae.
    Mitchell DA; Farh L; Marshall TK; Deschenes RJ
    J Biol Chem; 1994 Aug; 269(34):21540-6. PubMed ID: 8063791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.
    Bishop WR; Bond R; Petrin J; Wang L; Patton R; Doll R; Njoroge G; Catino J; Schwartz J; Windsor W
    J Biol Chem; 1995 Dec; 270(51):30611-8. PubMed ID: 8530497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location.
    Hart KC; Donoghue DJ
    Oncogene; 1997 Feb; 14(8):945-53. PubMed ID: 9050994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ras/cholesterol connection: implications for ras oncogenicity.
    Cox AD; Der CJ
    Crit Rev Oncog; 1992; 3(4):365-400. PubMed ID: 1420445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid.
    Kinsella BT; Erdman RA; Maltese WA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8934-8. PubMed ID: 1924354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
    Farh L; Mitchell DA; Deschenes RJ
    Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoproteolytic processing of a farnesylated peptide in vitro.
    Ashby MN; King DS; Rine J
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4613-7. PubMed ID: 1584798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21.
    Mizuno T; Kaibuchi K; Yamamoto T; Kawamura M; Sakoda T; Fujioka H; Matsuura Y; Takai Y
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6442-6. PubMed ID: 1907371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases.
    Michaelson D; Ali W; Chiu VK; Bergo M; Silletti J; Wright L; Young SG; Philips M
    Mol Biol Cell; 2005 Apr; 16(4):1606-16. PubMed ID: 15659645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification of low molecular mass GTP-binding proteins by isoprenoid.
    Maltese WA; Sheridan KM; Repko EM; Erdman RA
    J Biol Chem; 1990 Feb; 265(4):2148-55. PubMed ID: 2105317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.
    Der CJ; Cox AD
    Cancer Cells; 1991 Sep; 3(9):331-40. PubMed ID: 1751286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.